CYCLOPHARM LIMITED — Director's Dealing 2015

Jul 13, 2015

Appendix 3Y Change of Director’s Interest Notice

Rule 3.19A.2

Appendix 3Y

Change of Director’s Interest Notice

Information or documents not available now must be given to ASX as soon as available. Information and documents given to ASX become ASX’s property and may be made public.

Introduced 30/09/01 Amended 01/01/11

Name of entity CYCLOPHARM LIMITED ABN 74 116 931 250

We (the entity) give ASX the following information under listing rule 3.19A.2 and as agent for the director for the purposes of section 205G of the Corporations Act.

Name of Director	James McBrayer
Date of last notice	29/1/2015

Part 1 - Change of director’s relevant interests in securities

In the case of a trust, this includes interests in the trust made available by the responsible entity of the trust

Note: In the case of a company, interests which come within paragraph (i) of the definition of “notifiable interest of a director” should be disclosed in this part.

Direct or indirect interest	Direct
Nature of indirect interest (including registered holder) Note: Provide details of the circumstances giving rise to the relevant interest.	N/A
Date of change	13/7/2015
No. of securities held prior to change	1,755,274
Class	Ordinary Shares
Number acquired	1,721,554
Number disposed	Nil
Value/Consideration Note: If consideration is non-cash, provide details and estimated valuation	Not applicable
No. of securities held after change	3,476,828

• See chapter 19 for defined terms.

01/01/2011 Appendix 3Y Page 1

Appendix 3Y Change of Director’s Interest Notice

Nature of change Example: on-market trade, off-market trade, exercise of options, issue of securities under dividend reinvestment plan, participation in buy-back

13/7/2015 : 1,721,554 LTIP Shares acquired for $0.90 each under a limited recourse loan facility provided by the Company

Part 2 – Change of director’s interests in contracts

Note: In the case of a company, interests which come within paragraph (ii) of the definition of “notifiable interest of a director” should be disclosed in this part.

==> picture [434 x 319] intentionally omitted <==

----- Start of picture text -----

Detail of contract Nil
Nature of interest Nil
Name of registered holder Nil
(if issued securities)
Date of change Nil
No. and class of securities to which Nil
interest related prior to change
Note: Details are only required for a contract in
relation to which the interest has changed
Interest acquired Nil
Interest disposed Nil
Value/Consideration Nil
Note: If consideration is non-cash, provide details
and an estimated valuation
Interest after change Nil
----- End of picture text -----

Part 3 –[+] Closed period

Were the interests in the securities or contracts detailed No above traded during a[+] closed period where prior written clearance was required? If so, was prior written clearance provided to allow the trade Not Applicable to proceed during this period? If prior written clearance was provided, on what date was this Not Applicable provided?

• See chapter 19 for defined terms.

Appendix 3Y Page 2

01/01/2011